MOSCOW, October 19 - RIA Novosti. An international group of scientists has identified a biomarker, the presence of which allows you to determine the severity of the course of coronavirus infection. The research results were published in the scientific journal EMBO Molecular Medicine .
Experts have found that the course of the disease is influenced by the expression of the hFwe-Lose gene - the synthesis of the protein or RNA that it encodes.
"In patients with acute lung injury, the level of this biomarker was higher in the lower airways and at sites of cell death," the article says.
The hFwe-Lose level can be determined using a nasal swab.
The accuracy of predicting death or severe disease based on hFwe-Lose was 87.8-100%. The authors emphasized that the presented method turned out to be much more effective than when relying on parameters such as the patient's age and state of health.
Scientist working in the laboratory - RIA Novosti, 1920, 15.10.2021
October 15, 12:34 PM
Swiss inventor of antiseptic put forward a version of the origin of COVID-19
Since the beginning of the pandemic, more than 240 million cases of coronavirus infection have been recorded worldwide. 4.9 million people became victims of the disease caused by the infection. The most difficult situation has developed in the USA , India and Brazil .
In Russia, during the epidemic, 225,325 people died, more than eight million people were infected with SARS-CoV-2. Today the anti-virus mortality record has been updated in the country: 1015 deaths have been confirmed per day. In different regions, measures to combat infection began to be tightened.
Vaccination remains the most reliable way to protect against coronavirus. According to the head of the Ministry of Health, Mikhail Murashko, the percentage of vaccinated among seriously ill COVID-19 is less than 0.03%, while the vast majority of patients in hospitals are unvaccinated. At the end of September, the WHO announced the connection of mortality from SARS-CoV-2 with the refusal of preventive immunization.